Effect of transfer of synthetic double-stranded cis-element "decoy" oligodeoxynucleotides(ODNs) on neointimal thickening.
合成双链顺式元件“诱饵”寡脱氧核苷酸(ODN)转移对新内膜增厚的影响。
基本信息
- 批准号:11671166
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Background--Progressive neointimal thickening and restenosis remain major critical problems limiting the long-term efficacy of percutaneous transluminal coronary angioplasty or bypass surgery to treat subjects with vascular occlusive diseases. We examined the role of transfer of synthetic double-stranded cis-element "decoy" oligodeoxynucleotides(ODNs) in case of balloon injured rabbit carotid arteries and effects of these ODNs on neointimal thickening were investigated.Methods and Results--Transfection of flurescein isothiocyante(FITC)-labeled ODNs, using the hemagglutinating virus of Japan(HVJ)-liposome method, resulted in widespread distribution of fluorescent nuclear signals over the entire medial layer, while direct transfer of unmodified FITC-labeled ODNs showed patchy and scattered distribution in balloon injured rabbit carotid arteries. The gel mobility shift revealed that AP-1 DNA binding was activated, and that the AP-1 decoy ODNs reduced AP-1 DNA binding activity, as a result of specific binding affinity to AP-1 in vivo. In morphometric analyses, AP-1 decoy ODNs led to a significant reduction in the neointimal area and a significant reduction in cell number of human aortic smooth muscle cells, under conditions of platelet-derived growth factor stimulation.Conclusions--As AP-1 decoy ODNs transfection in vivo dramatically prevented neointimal thickening in balloon injured arteries, AP-1 may be an useful molecular target for gene therapy to reduce restenosis.
背景-进行性新生内膜增厚和再狭窄仍然是限制经皮冠状动脉腔内成形术或搭桥手术治疗血管闭塞疾病患者的长期疗效的主要关键问题。我们研究了人工合成的双链顺式元件“诱饵”寡核苷酸(ODN)在兔颈动脉球囊损伤后的作用,并观察了这些ODN对血管内膜增厚的影响。方法与结果--用日本血凝病毒(HVJ)-脂质体方法将荧光素异硫氰酸酯(FITC)标记的ODN导入球囊损伤的兔颈动脉,发现荧光核信号在整个中层广泛分布,而直接转移未经修饰的ODN在球囊损伤的兔颈动脉内呈斑片状和散布分布。凝胶迁移率的变化表明,AP-1DNA结合被激活,而AP-1诱骗ODN降低了AP-1DNA结合活性,这是体内与AP-1特异结合的结果。形态计量学分析显示,在血小板衍生生长因子刺激下,AP-1诱骗寡核苷酸可使人动脉内膜面积显著减少,细胞数显著减少。结论AP-1诱骗寡核苷酸体内转染可显著抑制球囊损伤动脉内膜增厚,AP-1有望成为基因治疗减少再狭窄的分子靶点。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawasaki K, Komori K, et al.: "Inhibition of 12(S)-Hydroxy eicosatetraenoic acid (12-HETE) production suppressed the intimal hyperplasia caused by poor runoff conditions in the rabbit autologous vein grafts."J Cardiovasc Pharmacol. 36. 555-563 (2000)
Kawasaki K、Komori K 等人:“抑制 12(S)-羟基二十碳四烯酸 (12-HETE) 的产生可抑制兔自体静脉移植物中因径流条件不良引起的内膜增生。”J Cardiovasc Pharmacol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeuchi K, Komori K, Ohta S, Shimada M, Yonemitsu Y, Sugimachi K.: "A simultaneous resection of a concomitant abdominal aortic aneurysm and hepatocellular carcinoma : two cases."Int Surg. 85. 158-162 (2000)
Takeuchi K、Komori K、Ohta S、Shimada M、Yonemitsu Y、Sugimachi K.:“同时切除伴发的腹主动脉瘤和肝细胞癌:两个病例。”Int Surg。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeuchi K,Komori K, et al.: "A simultaneous resection of a concomitant abdominal aortic aneurysm and hepatocellular carcinoma : two cases."Int Surg. 85. 158-162 (2000)
Takeuchi K、Komori K 等人:“同时切除并发腹主动脉瘤和肝细胞癌:两个病例。”Int Surg。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Onohara T,Fujinaga Y,Komori K,et al.: "Increased prostacyclin production after percutaneous transluminal angioplasty of the iliac artery for atherosclerosis obliterans"Panminerave Med. 41. 1-4 (1999)
Onohara T、Fujinaga Y、Komori K 等人:“治疗动脉粥样硬化闭塞症的髂动脉经皮腔内血管成形术后增加前列环素的产生”Panminerave Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Onohara T, Komori K, Yamamura S, Fujinaga Y, Sugimachi K.: "Modulation of platelet aggregation after percutaneous transluminal angioplasty of the iliac artery for atherosclerosis obliterans."Surgery. 127. 87-91 (2000)
Onohara T、Komori K、Yamamura S、Fujinaga Y、Sugimachi K.:“针对动脉粥样硬化闭塞症的髂动脉经皮腔内血管成形术后血小板聚集的调节。”手术。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOMORI Kimihiro其他文献
KOMORI Kimihiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOMORI Kimihiro', 18)}}的其他基金
Functions of Nitric Oxide and Endothelium-derived Hyperpolarizing Factor are impaired in Poor Run-off Autogenous Rabbit Arterial Grafts
兔自体动脉移植物径流不良时一氧化氮和内皮源性超极化因子的功能受损
- 批准号:
17H04290 - 财政年份:2017
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New therapeutic approach for targeting endothelium-derived hyper polarizing factor in the intimal hyperplasia of vein and artery grafts.
针对静脉和动脉移植物内膜增生中的内皮衍生超极化因子的新治疗方法。
- 批准号:
25293295 - 财政年份:2013
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Adipocytokine is the new target of the strategy for the prevention of intimal hyperplasia
脂肪细胞因子是预防内膜增生策略的新靶点
- 批准号:
21390357 - 财政年份:2009
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New Gene Therapy-Controlled Release of siRNA as to Midkine Inhibits the Intimal Hyperplasia in Vein Grafts
新基因疗法控制释放中期因子 siRNA 抑制静脉移植物内膜增生
- 批准号:
18390344 - 财政年份:2006
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The New Strategy of Gene Therapy for the Patients with Pheripheral Arterial Disease
周围动脉疾病基因治疗新策略
- 批准号:
15390375 - 财政年份:2003
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Essential role of monocyte chemoattractant protein-1 (MCP1) in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits
单核细胞趋化蛋白-1 (MCP1) 在高胆固醇血症兔球囊血管成形术后再狭窄变化(新内膜增生和收缩性重塑)发展中的重要作用
- 批准号:
13671241 - 财政年份:2001
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of gene transfection on the intimal thickening of the autogeneous vein grafts
基因转染对自体静脉移植物内膜增厚的影响
- 批准号:
08671375 - 财政年份:1996
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of shear stress on the intimal hyperplasia of autogenous Vein grafts
剪切应力对自体静脉移植物内膜增生的影响
- 批准号:
05807107 - 财政年份:1993
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
- 批准号:
MR/Z50385X/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
- 批准号:
10087446 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Collaborative R&D
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
- 批准号:
MR/X031039/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
- 批准号:
10090933 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
EU-Funded
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
- 批准号:
2888189 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Studentship
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
- 批准号:
EP/X024563/1 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
- 批准号:
2240683 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
- 批准号:
23K15643 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
- 批准号:
23K19673 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Research Activity Start-up